References
- Abegunde D, Stanciole A. An estimation of the economic impact of chronic noncommunicable diseases in selected countries. WHO Department of Chronic Diseases and Health Promotion (CHP); 2006.
- International Statistical Classification of Diseases and Related Health Problems. 10th Revision Version for 2006. Available from: http://apps.who.int/classifications/apps/icd/icd10online2006/.
- Leszczyńska M (2013), Epidemiologia cukrzycy. Magazyn Pielęgniarek i Położnych, nr 2013 7–8.
- Tatoń J, Czech A. Epidemiologia cukrzycy. Diabetologia. Tom 1. PZWL, Warszawa. 2001;14–26.
- Hamera A, Olech A, Koza A, et al. Risk factors for major leg amputation in patients treated endovascularly due to critical limb ischaemia. Via Medica. 2015;21(4):122–128.
- Sinha R (2013). Adjustments to amputation and artificial limb, and quality of life in lower limb amputees. University of Groningen/UMCG research database. Available from: http://www.rug.nl/research/portal/.
- EY. Metodyka pomiaru kosztów pośrednich w polskim systemie ochrony zdrowia. Warszawa. 2013. EY. Available from: http://www.ey.com/Publication/vwLUAssets/Raport_Metodyka_pomiaru_kosztow_posrednich_17.09/$FILE/Raport_Metodyka%20pomiaru%20kosztow%20posrednich_17.09.pdf
- Tharkar S, Devarajan A, Kumpatla S, et al. The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes Res Clin Pract. 2010;89(3):334–340.
- De Azevedo AB, Ferraz MB, Ciconelli RM. Indirect sosts of rheumatoid arthritis in Brazil. Value Health. 2008;11(5):869–877.
- Lofland J, Pizzi L, Firck K. A review of health-related workplace productivity loss instruments. Pharmacoeconomics. 2004;22(3):165–184.
- American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008 Mar;31(3):596–615.
- International Diabetes Federation. Diabetes Atlas 6th edition 2013. Available from: www.idf.org/diabetesatlas.
- Polakowska M, Piotrowski W. Incidence of diabetes in the Polish population – WOBASZ. Polskie Archiwum Medycyny Wewnętrznej. 2011;(2011)(121):5.
- Szczeklik A. Interna Szczeklika. Podręcznik chorób wewnętrznych 2016. Kraków: Medycyna Praktyczna; 2016.
- Kawalec P, Kielar M, Pilc A. Koszty leczenia cukrzycy typu 1 i 2 w Polsce. Diabetologia Praktyczna, tom 7, nr 5; 2006.
- Kinalska I, Niewada M, Głogowski C, et al. Koszty cukrzycy typu 2 w Polsce (Badanie CODIP). Diabetologia Praktyczna. 2004;5(1):1–8.
- Novo Nordisk C. Ukryta Pandemia. Sytuacja w Polsce. Edycja; 2013. Available from: http://www.stopacukrzycowa.com/cukrzyca_ukryta_pandemia_polska_raport_2013.pdf.
- Ch. B, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5:423–430.
- Png M, Yoong J, Phan T, et al. Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010–2050. Png Et Al. BMC Public Health. 2016;16:153.
- Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics. 2015;2015(33):811–831.
- Ulrich S, Holle R, Wacker M, et al. Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies. BMJ Open. 2016;6:e012527.